Earnings History Data for Aptose Biosciences, Inc. (APTO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aptose Biosciences, Inc.

Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-05-2022 AH 4:00 PM ET
(May 9)
APTO Aptose Biosciences, Inc. 112.52 -0.12 -0.15 -0.18 Aptose Biosciences GAAP EPS of -$0.12 beats by $0.02
[5/9/2022 4:33 PM]
1.07 -0.04 
(-4.02%)
1.09 -0.03 
(-2.68%)
1.00 - 5.78 742,253 530,000 253
22-03-2022 AH 4:00 PM ET
(Mar 22)
APTO Aptose Biosciences, Inc. 108.52 -0.27 -0.18 -0.17 Aptose Biosciences GAAP EPS of -$0.27 misses by $0.11
[3/22/2022 4:15 PM]
1.23 -0.05 
(-4.30%)
1.14 -0.14 
(-10.94%)
1.00 - 7.20 531,225 380,000 15,657
11-11-2021 AH 4:00 PM ET
(Nov 11)
APTO Aptose Biosciences, Inc. 217.03 -0.13 -0.17 -0.15 Aptose Biosciences EPS beats by $0.04
[11/11/2021 4:37 PM]
2.65 0.25 
(10.42%)
2.56 0.16 
(6.67%)
2.02 - 7.27 1,941,901 910,000 65,162
03-08-2021 AH 4:00 PM ET
(Aug 3)
APTO Aptose Biosciences, Inc. 235.33 -0.15 -0.18 -0.21 Aptose Biosciences EPS beats by $0.04
[8/3/2021 4:04 PM]
2.61 -0.02 
(-0.95%)
2.66 0.03 
(1.14%)
2.55 - 7.27 767,135 1,030,000 9,822
04-05-2021 AH 4:00 PM ET
(May 4)
APTO Aptose Biosciences, Inc. 492.53 -0.18 -0.17 -0.15 Aptose Biosciences EPS misses by $0.01
[5/4/2021 4:02 PM]
4.91 -0.58 
(-10.56%)
5.35 -0.14 
(-2.55%)
3.39 - 9.00 2,144,344 780,000 17,692
23-03-2021 AH 4:00 PM ET
(Mar 23)
APTO Aptose Biosciences, Inc. 341.19 -0.17 -0.16 -0.13 Aptose Biosciences EPS in-line
[3/23/2021 4:04 PM]
5.95 2.28 
(62.13%)
5.35 1.68 
(45.78%)
3.39 - 9.00 173,104,404 1,050,000 5,921,639
10-11-2020 AH 4:00 PM ET
(Nov 10)
APTO Aptose Biosciences, Inc. 414.67 -0.15 -0.18 -0.12 Aptose Biosciences EPS beats by $0.04
[11/10/2020 4:03 PM]
5.21 0.68 
(15.01%)
4.59 0.06 
(1.32%)
2.32 - 9.25 1,831,945 762,618 14,231
04-08-2020 AH 4:00 PM ET
(Aug 4)
APTO Aptose Biosciences, Inc. 439.08 -0.21 -0.15 -0.13 Aptose Biosciences EPS misses by $0.05
[8/4/2020 4:12 PM]
5.48 0.34 
(6.61%)
5.15 0.01 
(0.19%)
1.82 - 9.25 1,106,502 1,075,477 24,385
05-05-2020 AH 4:00 PM ET
(May 5)
APTO Aptose Biosciences, Inc. 519.42 -0.15 -0.10 -0.14 Aptose Biosciences EPS misses by $0.05
[5/5/2020 4:07 PM]
7.11 0.29 
(4.25%)
6.95 -0.16 
(-2.25%)
1.81 - 9.25 762,436 1,086,025 850